NAVAo — Navamedic ASA Income Statement

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual income statement for Navamedic ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	189	210	278	382	512
Cost of Revenue
Gross Profit	57.6	70.3	112	164	199
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	199	215	267	328	488
Operating Profit	-10.1	-4.93	11.5	54	23.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-15.5	-16.6	2.36	42.5	10.8
Provision for Income Taxes
Net Income After Taxes	-16.3	-16.5	0.618	29.4	3.81
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	27.9	-16.5	0.618	29.4	3.81
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	27.9	-16.5	0.618	29.4	3.81
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.39	-1.14	0.038	1.33	0.22
Dividends per Share